• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

About april@madhedgefundtrader.com

This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 2566 entries already.

Entries by april@madhedgefundtrader.com

Tech Letter

The Truth About Automation And Banking

Automation is taking place at warp speed, displacing employees from all walks of life.  According to a recent report, the U.S. financial industry will depose of 400,000 workers in the next decade because of automating efficiencies. Yes, humans are going the way of the dodo bird, and banking will effectively become algorithms working for a

Jacque's Post

December 27, 2024

  (THE LONG-TERM INFLATION TARGET MAY BE 2%, BUT THE REALITY WILL LIKELY BE QUITE DIFFERENT) December 27, 2024   Hello everyone The era of stable inflation is over. Yes, the Fed might get inflation down to close to 2%, but I believe they will struggle to keep it there. Let’s check out the reasons

Diary, Newsletter, Summary

December 27, 2024

Global Market Comments December 27, 2024 Fiat Lux Featured Trade: (HOW MY MAD HEDGE AI MARKET TIMING ALGORITHM WORKS)

Biotech Letter

December 26, 2024

Mad Hedge Biotech and Healthcare Letter December 26, 2024 Fiat Lux   Featured Trade: (PHASE 2 OR NOT PHASE 2: THAT'S NOT EVEN A QUESTION IN 2025) (LLY), (NVO)

Biotech Letter

Phase 2 Or Not Phase 2: That's Not Even A Question In 2025

I had dinner with a veteran biotech investor at San Francisco's Waterbar earlier this month, watching the Bay Bridge lights while discussing what's coming for biotech in 2025. "The game is changing," he said, picking at his salmon. "It's not about platform promises anymore. Show me the Phase 2 data, or don't show up at

Diary, Newsletter, Summary

December 26, 2024

Global Market Comments December 26, 2024 Fiat Lux   SPECIAL ISSUE ABOUT THE FAR FUTURE Featured Trade: (PEAKING INTO THE FUTURE WITH RAY KURZWEIL), (GOOG), (INTC), (AAPL), (TXN)

Biotech Letter

December 24, 2024

Mad Hedge Biotech and Healthcare Letter December 24, 2024 Fiat Lux   Featured Trade: (THE LAB RESULTS ARE IN) (GILD), (TSLA), (WVE), (EDIT), (CRSP), (LLY), (NVO), (WMT), (CVS), (CCCC), (RHHBY)

Biotech Letter

The Lab Results Are In

I found myself gridlocked in Bay Area traffic a few days ago, inching past Gilead's (GILD) sprawling Foster City headquarters, when my phone lit up with a call from an old friend at Goldman. “Alright, tell me—what’s the real story with biotech this year?” she asked, her tone hovering somewhere between curiosity and exasperation. “Half

Diary, Newsletter, Summary

December 24, 2024

Global Market Comments December 24, 2024 Fiat Lux   Featured Trade: (THE NEXT COMMODITY SUPER CYCLE HAS ALREADY STARTED), (COPX), (GLD), (FCX), (BHP), (RIO), (SIL), (PPLT), (PALL), (GOLD), (ECH), (EWZ), (IDX)

Tech Letter

December 23, 2024

Mad Hedge Technology Letter December 23, 2024 Fiat Lux   Featured Trade: (THE FUTURE IS HERE) (NO CODE)

Page 61 of 232«‹5960616263›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top